Article info
PDFOriginal article
Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary
- Correspondence to Tomokazu Umezu, Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; t-ume{at}med.nagoya-u.ac.jp
Citation
Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary
Publication history
- Accepted July 14, 2010
- First published October 23, 2010.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.